Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRDFCRDF
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CARDIFF ONCOLOGY INC

GOLDMAN SACHS GROUP INC holds 120,827 shares of CRDF (CARDIFF ONCOLOGY INC), worth $157,076 as of 2026-Q2. The position was decreased (-10.9% shares).

Current Value

$157,076

Current Shares

120,827

Total Value Change

-$507,092

Total Shares Change

-32,207

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
120,827
-10.9%
$157,0760.0%$1.30
0
2026-Q1
Decreased
135,598
-64.8%
$219,6690.0%$1.89
0
2025-Q4
Decreased
385,086
-15.3%
$1.1M0.0%$2.87
0
2025-Q3
Increased
454,726
+495.7%
$936,7360.0%$2.08
40
2025-Q2
Decreased
76,334
-28.8%
$240,4520.0%$3.15
0
2025-Q1
Decreased
107,133
-30.0%
$336,3970.0%$3.29
0
2024-Q4
New
153,034
-
$664,1680.0%$4.26
34

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used